The invention provides methods and compositions for treating, preventing and/ or remedying psoriasis, based on compounds that have a calcitonin-related gene peptide (CGRP) antagonistic effect. Methods are also disclosed for identifying compounds with CGRP antagonist activity which thereby are suitable candidate compounds for treating psoriasis.Upotreba CGRP antagonista za proizvodnju leka za tretiranje, prevenciju ili lečenje psorijaze.Prijava sadrži još 12 patentnih zahteva.